The Latest Breaking News from Arthritis

Rory was only 20 years old when he was diagnosed with arthritis

A therapeutic pool at Albany hospital sits empty despite arthritis sufferers appealing to health authorities for its reopening.

A recent study found walking for exercise can reduce new frequent knee pain among people age 50 and older diagnosed with knee osteoarthritis.

Olumiant (baricitinib), a Janus kinase (JAK) inhibitor, was developed by Incyte Corp (NASDAQ:INCY) and launched in collaboration with Eli Lilly And Co (NYSE:LLY), received FDA approval for hair loss disorder known as alopecia areata (AA). Olumiant was first approved for the treatment of rheumatoid arthritis (RA) in 2018. The above nod is expected to…

If you are living with any of these musculoskeletal conditions you may be eligible for PIP.

TLC BioSciences has entered a commercialization agreement with Endo International plc (NASDAQ:ENDP) for the U.S. rights of TLC599, a proprietary BioSeizer sustained-release injectable in Phase 3 development for osteoarthritis pain. Under the agreement signed with Endo's subsidiary Endo Ventures Limited (EVL), TLC will primarily be responsible for developing the product, and EVL for obtaining regulatory…

ROCHESTER, Minn. — For people with severe arthritis pain in the knee joints, knee replacement is a viable option to improve their quality of life. Orthopedic surgeons now have a new tool for knee replacement: augmented reality.

Attendance Allowance is a benefit designed to help cover your costs if you have a disability severe enough that you need someone to help look after you - here's how it works

Arthritis is a painful condition known to negatively impact a person’s day-to-day life. When pain does strike, finding ways and methods to help reduce these symptoms is crucial, with milk said to help particularly for knee pain

Experts reveal the pros and cons of cracking your knuckles and other joints in your body.

Pfizer Inc (NYSE:PFE) will sell over 20 patent-protected drugs and vaccines at not-for-profit prices to 45 of the world's poorest countries. Under the program, Pfizer will begin shipping the medicines first to Ghana, Malawi, Rwanda, Senegal, and Uganda before the end of this year, Chief Executive Albert Bourla said in an interview. This will…